Kim Pettersson
kim.pettersson@utu.fi Kiinamyllynkatu 10 Turku |
- A cancer-specific detection of serum CA125 improves differential diagnosis of epithelial ovarian cancer from benign conditions. (2018)
- Clinical Cancer Research
- CA125 glycoform assay improves the performance of conventional CA125 in the diagnostics of epithelial ovarian cancer (2018)
- International Journal of Gynecological Cancer
- Direct immunoassay for free pregnancy-associated plasma protein A (PAPP-A) (2018)
- The Journal of Applied Laboratory Medicine
- Microparticle - based platform for point-of-care immunoassays (2018)
- Analytical Biochemistry
- A lateral flow immunoassay with upconverting nanoparticle-based detection for indirect measurement of interferon response by the level of MxA (2017)
- Journal of Medical Virology
- A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale (2017)
- European Journal of Epidemiology
- Improved cancer specificity in PSA assay using Aleuria aurantia lectin coated Eu-nanoparticles for detection (2017)
- Clinical Biochemistry
- Uusi lektiini-avusteinen määrityskonsepti parantamaan CA-125-kasvainmerkkiaineen munasarjasyöpäspesifisyyttä (2017)
- Kliin lab
- A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources (2016)
- Clinical Chemistry
- Anti-HCV immunoassays based on a multiepitope antigen and fluorescent lanthanide chelate reporters (2016)
- Journal of Virological Methods



